13.8 C
London
Sunday, April 14, 2024

Emerging Growth Conference 70 May 8 & 9 - Register now

Emerging Growth Conference 68

March 6 & 7, 2024

Agenda Wednesday March 6, 2024

A2Z Smart Technologies Corp. (NYSE: AZ) is a leading global provider of innovative technology solutions, specializing in the development and deployment of state-of-the-art smart cart platforms.

Keynote speaker: John Gildea, VP Corporate Communications

Shuttle Pharmaceuticals, Inc. (NASDAQ: SHPH) is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy.

Keynote speaker: Anatoly Dritschilo, MD, CEO & Chairman

Sigyn Therapeutics, Inc. (OTCQB: SIGYD SIGY) is a development-stage medical technology company headquartered in San Diego, California. The Company’s therapeutic candidates are each designed to overcome a clearly defined limitation in healthcare. 

Keynote speaker: James Allen Joyce, CEO

ASP Isotopes Inc. (NASDAQ: ASPI) is a pre-commercial stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries.

Keynote speaker: Paul Elliot Mann, CEO

SensTech, Inc. (NASDAQ: SNES), Inventors of ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, is committed to improving the health of the world by humanely managing animal pest populations through fertility control.

Keynote speaker: Joel L. Fruendt, President, CEO, & Director

Zoned Properties, Inc. (OTCQB: ZDPY) is a specialized real estate development firm for emerging and highly regulated industries, including regulated cannabis. The Company is redefining the approach to commercial real estate investment through its integrated growth services.

Keynote speaker: Bryan Mclaren, CEO

Citizens, Inc. (NYSE: CIA) is a diversified financial services company providing life, living benefits and final expense insurance and other financial products to individuals and small businesses in the U.S., Latin America, and Asia.

Keynote speakers: Gerald W. Shields, Vice Chairman and CEO Jeff Conklin, CFO

Kneat.com, Inc., (OTCQX: KSIOF) (TSX: KSI) is a Canadian company with operational headquarters in Limerick, Ireland, who develops and markets the next-generation Kneat Gx SaaS platform.

Keynote speaker: Edmund Ryan, CEO

Altima Resources Ltd. (OTC Pink: ARSLF) (TSXV: ARH) is a junior energy company engaged in the exploration and development of petroleum and natural gas in Canada. The company operates in the petroleum and natural gas industry.

Keynote speaker: Joe DeVries, CEO

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. 

Keynote speaker: Harry Simeonidis, President / CEO 

ZYUS Life Science Corporation (OTC Pink: ZLSCF) (TSXV: ZYUS) is a Canadian-based life sciences company focused on the global development and commercialization of cannabinoid-based pharmaceutical drug product candidates and innovative exempt market therapeutics.

Keynote speaker: Brent Zettl, CEO

Carbon Revolution, Plc. (NASDAQ: CREV) is the parent of Carbon Revolution Limited, an Australian technology company, which has successfully innovated, commercialized and industrialized the advanced manufacture of carbon fiber wheels for the global automotive industry.

Keynote speakers: Gerald Buckle, CFO, and Nick Batchelor, Commercial Director

Agenda Wednesday March 7, 2024

QuantaSing Group Limited (NASDAQ: QSG) is a leading online service provider in China dedicated to improving people’s quality of life and well-being by providing lifelong personal learning and development opportunities.

Keynote speaker: Tim Xie, Chief Financial Officer

FendX Technologies, Inc. (OTCQB: FDXTF) (CSE: FNDX) is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens.

Keynote speaker: Carolyn Myers, CEO

Tharimmune, Inc. (NASDAQ: THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.

Keynote speakers: Randy Milby, President Chairman & CEO, and Sireesh Appajosyula, COO

AseptiScope, Inc., driven to bring forward novel solutions that ensure “Infection Protection for Clinician & Patient.”, is a privately funded San Diego based company founded in 2016 and led by clinical innovation experts, leading medical researchers, and practicing physicians.

Keynote speaker: Scott W Mader – Founder & CEO

Trinity Biotech, Plc. (NASDAQ: TRIB) develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. 

Keynote speakers: John Gillard – President & CEO, and Des Fitzgerald, Interim CFO

AGBA Group Holding Limited (NASDAQ: AGBA) is a leading one-stop financial supermarket based in Hong Kong offering the broadest set of financial services and healthcare products in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) through a tech-led ecosystem, enabling clients to unlock the choices that best suit their needs.

Keynote speaker: Mr. Wing-Fai Ng, CEO

Canoo Technologies, Inc. (NASDAQ: GOEV) has developed breakthrough electric vehicles that are reinventing the automotive landscape with their pioneering technologies, unique design, and business model that spans multiple owners across the full lifecycle of the vehicle.

Keynote speaker: Greg Ethridge, CFO

Ideanomics (NASDAQ: IDEX) is a global group with a simple mission: accelerating the commercial adoption of electric vehicles by bringing together vehicles, charging and financing solutions under one roof. 

Keynote speaker: Alfred P. Poor – CEO & Director

ARway.ai (CSE: ARWY) (OTCQB: ARWYF) is a spatial computing platform powered by artificial intelligence (AI) providing an array of augmented reality (AR) experiences for indoor spaces.

Keynote speaker: Evan Gappelberg, CEO

Clearday, Inc. (OTCQX: CLRD) is, with a focus on personalized care and groundbreaking technology, at the forefront of redefining the standards of senior living.

Keynote speakers: James Walesa, President / CEO, and Dan Policy, Corporate Development

Regen BioPharma Inc. (OTC Pink: RGBP) is a biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space.

Keynote speakers: David Koos, President / CEO, Harry M. Lander, Ph.D. Senior Scientific Consultant, and Annette Marleau, PHD

Ideal Power (NASDAQ: IPWR) is pioneering the development and commercialization of its broadly patented bidirectional semiconductor power switch, creating highly efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS/data center, solid-state circuit breaker and other industrial and military applications.

Keynote speaker: Dan Brdar, President, CEO & Director

Peninsula Energy Ltd.’s (OTCQB: PENMF) (ASX: PEN) 100% owned Lance Project, one of the largest uranium projects in the United States, is undergoing a project transformation initiative to transition to a low cost and environmentally friendly low pH ISR operation.

Keynote speaker: Wayne W. Heili, MD, CEO & Director

Myriad Uranium Corp. (OTCQB: MYRUF) (CSE: M) is a uranium exploration company with an earnable 75% interest in the Copper Mountain Uranium Project in Wyoming, USA. 

Keynote speaker: Thomas David Lamb, President, CEO, Company Secretary & Director

GTI Energy, Ltd. (OTC Pink: GTRIF) (ASX: GTR) is part of Wyoming’s Insitu Recovery (ISR) uranium mining renaissance, focused on exploring for, defining and developing economic ISR Uranium resources.

Keynote speaker: Bruce Lane, Executive Director, CEO

The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.

Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.

The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

Thank you for your interest in our conference, and we look forward to your participation in future conferences.